The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Novo Nordisk ADR (NYSE: NVO) closed the day trading at $69.72 down -5.49%% from the previous closing price of $73.77. In other words, the price has decreased by -$5.49% from its previous closing price. On the day, 15.32 million shares were traded.
Ratios:
For a better understanding of NVO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.43. For the most recent quarter (mrq), Quick Ratio is recorded 0.56 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.70.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 30 ’25 when Novo Nordisk A/S bought 921,897 shares for $2.14 per share.
Valuation Measures:
As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.68, and their Forward P/E ratio for the next fiscal year is 14.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.38 while its Price-to-Book (P/B) ratio in mrq is 15.44.
Stock Price History:
Over the past 52 weeks, NVO has reached a high of $148.15, while it has fallen to a 52-week low of $57.00. The 50-Day Moving Average of the stock is 2.00%, while the 200-Day Moving Average is calculated to be -23.47%.
Shares Statistics:
A total of 3.37B shares are outstanding, with a floating share count of 3.37B. Insiders hold about 0.00% of the company’s shares, while institutions hold 9.71% stake in the company.
